Mwsm. Dooper et al., DEFECT IN POTENTIATION OF ADENYLYL-CYCLASE CORRELATES WITH BRONCHIAL HYPERREACTIVITY, Journal of allergy and clinical immunology, 96(5), 1995, pp. 628-634
Background: Adenylyl cyclase is a transmembrane signaling system invol
ved in the inhibition of cellular responses. Recently, we showed that
the activity of adenylyl cyclase may be potentiated by stimuli that in
duce an increase of cellular responses but that do not activate adenyl
yl cyclase. This is probably an important physiologic feedback mechani
sm that prevents cells from becoming ''overstimulated.'' Objective: Be
cause increased cellular activities are frequently observed in persons
with asthma, we hypothesized that a defect in potentiation of adenyly
l cyclase might be involved. Methods: Potentiation of isoprenaline-ind
uced adenosine cyclic monophosphate (cAMP) production with the mitogen
phytohemagglutinin (PHA; 45 mu g/ml) or the calcium ionophore A23187
(1 mu mol/L) was studied in peripheral blood mononuclear cells taken f
rom patients with asthma (n = 8) and healthy control subjects (n = 11)
. Results: Isoprenaline-induced cAMP production was potentiated signif
icantly in the healthy control subjects (PHA, 110% +/- 15%; A23187, 92
% +/- 25%). In contrast, potentiation was not seen with PHA ol A23187
in the total group of patients with asthma. However; some patients sho
wed weak potentiation, whereas in others PHA decreased isoprenaline-in
duced CAMP production. Moreover, the effect of PHA isoprenaline-induce
d cAMP production correlated significantly with the degree of bronchia
l hyperreactivity in patients with asthma (r = 0.96; p = 0.0001). Conc
lusions: The observed defect in signal transduction could play an impo
rtant part in bronchial hyperresponsiveness.